Metformin. Contraindications in heart failure reconsidered
Schmitt-Hönl, B.
Medizinische Monatsschrift für Pharmazeuten 31(4): 148-149
2008
ISSN/ISBN: 0342-9601 PMID: 18497248 Document Number: 616353
Document emailed within 1 workday
Related Documents
Hague, W.M.; Davoren, P.M.; Oliver, J.; Rowan, J. 2003: Contraindications to use of metformin. Metformin may be useful in gestational diabetes Bmj 326(7392): 762; Author Reply 762Widimsky, J. 1975: Heart failure. Pathogenesis of heart failure and diagnosis of the incipient stage of heart failure Cor et Vasa 17(4): 302-314
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Takahashi, H. 2007: Pathophysiology of heart failure and the biomarkers; brain natriuretic hormone as the class-1 recommendation by the new Japanese Guideline for Heart Failure Rinsho Byori. Japanese Journal of Clinical Pathology 55(12): 1088-1096
Feenstra, J.; Heerdink, E.R.; Grobbee, D.E.; Stricker, B.H.Ch. 2002: Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study Archives of Internal Medicine 162(3): 265-270
Landström, N.; Kesek, M.; Jensen, S.M. 2013: Too few patients get heart failure pacemakers. it can provide better treatment in heart failure and left bundle branch block Lakartidningen 110(5): 216-219
Correia, J.; Silva, Fátima.Franco.; Roque, C.; Vieira, H.; Providéncia, Lís.Augusto. 2007: Impact of a specialized outpatient heart failure follow-up program on hospitalization frequency and functional status of patients with advanced heart failure Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 26(4): 335-343
Kanoksilp, A.; Hengrussamee, K.; Wuthiwaropas, P. 2009: A comparison of one-year outcome in adult patients with heart failure in two medical setting: heart failure clinic and daily physician practice Journal of the Medical Association of Thailand 92(4): 466-470
Gomberg-Maitland, M.; Baran, D.A.; Fuster, V. 2001: Treatment of congestive heart failure: guidelines for the primary care physician and the heart failure specialist Archives of Internal Medicine 161(3): 342-352
Kuch, M.; Janiszewski, M.; Janiszewski, M.ł; Braksator, W.; Mamcarz, A.; Sadkowska, K.; Kuch, J.; Dłuzniewski, M.ła. 2006: Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 20(117): 285-288
Komajda, M. 1999: Neurohormonal mechanisms in congestive heart failure with special reference to diastolic heart failure Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 18 Suppl. 5: V93-V96
Guimarães, A.C. 1993: Congestive heart failure. Concept of diastolic and systolic heart failure. A didactic presentation Arquivos Brasileiros de Cardiologia 60(1): 13-14
Ahmed, A. 2009: DEFEAT - Heart Failure: a guide to management of geriatric heart failure by generalist physicians Minerva Medica 100(1): 39-50
O'Connell, J.B.; Cobb, A.B. 1996: Heart failure evaluation and treatment in Mississippi: results from a survey of the Mississippi Foundation for Medical Care. Heart Failure Study Group Journal of the Mississippi State Medical Association 37(7): 648-652
Van Dijk, P.R.; Landman, G.W.D.; Bilo, H.J.G. 2012: Role of metformin in diabetes treatment--is metformin falling from grace? Nederlands Tijdschrift Voor Geneeskunde 156(43): A5297
Azuma, J. 1994: Long-term effect of taurine in congestive heart failure: preliminary report. Heart Failure Research with Taurine Group Advances in Experimental Medicine and Biology 359: 425-433
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108
Tarantini, L.; Cioffi, G.; Opasich, C.; Di Lenarda, A.; Pulignano, G.; Del Sindaco, D.; De Feo, S.; Stefenelli, C.; Russo, P.; Catania, G. 2004: Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 441-449
Haydardedeoglu, B.; Simsek, E.; Kilicdag, E.B.; Bagis, T. 2009: Metabolic and endocrine effects of metformin and metformin plus cyclic medroxyprogesterone acetate in women with polycystic ovary syndrome International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 105(1): 32-35
Bredella, M.A.; McManus, S.; Misra, M. 2013: Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome Clinical Endocrinology 79(2): 199-203